Haploidentical Bone Marrow Transplantation in 2015 and Beyond

Area of Science:

• Hematology
• Transplantation Immunology

Background:

• Limited availability of HLA-identical sibling stem cell donors.
• High cost of alternative donors like matched unrelated donors and cord bloods, especially in developing countries.
• Need for accessible and affordable stem cell allografts.

Purpose of the Study:

• To highlight the growing importance of alternative stem cell donors.
• To discuss haploidentical stem cell transplantation as a viable and future-oriented option.
• To explore cost-reduction strategies for haploidentical stem cell transplantation.

Main Methods:

• Utilizing reduced-intensity conditioning regimens.
• Implementing outpatient procedures for stem cell transplantation.
• Employing post-transplant cyclophosphamide.

Main Results:

• Long-term outcomes of haploidentical stem cell allografts are comparable to cord blood stem cell allografts.
• Cost-effective modifications enhance the feasibility of haploidentical stem cell transplantation.

Conclusions:

• Haploidentical stem cell transplantation is a critical and evolving treatment in hematology.
• Improvements in procedure efficiency and cost reduction will increase patient access to this therapy.
• This approach holds significant promise for expanding allogeneic stem cell transplantation options.